Clinical Trial Update: Pilot Study of OXP001(2) and Brufen in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 pilot study of OXP001(2) with Brufen in healthy subjects has completed, evaluating safety in the context of gastroduodenal erosions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroduodenal Erosions

Drugs mentioned

• Brufen (ibuprofen)
• OXP001(2)

Snippet

Sponsor: Oxford Pharmascience Ltd | Conditions: Gastroduodenal Erosions | Phase 1 | Status: COMPLETED